ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0899

Performance of the Foot Function Index Questionnaire in Patients with Rheumatoid Arthritis

Joan Manuel Dapeña, Lucia Alascio, Eliana Rebeca Serrano, Juan Manuel Bande, Maria Alejandra Medina, Diana Silvia Klajn, Jose Angel Caracciolo and Silvia Beatriz Papasidero, Hospital General de Agudos Dr. Enrique Tornu, Buenos Aires, Argentina

Meeting: ACR Convergence 2022

Keywords: foot, functional status, Measurement, physical function, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2022

Title: RA – Diagnosis, Manifestations, and Outcomes Poster II

Session Type: Poster Session B

Session Time: 9:00AM-10:30AM

Background/Purpose: Multiple questionnaires and objective assessment tools have been developed to determine functional compromise in Rheumatoid Arthritis (RA). One of the most used tools to measure the impact on foot joints is the Foot Function Index (FFI), self-administered questionnaire of 23 items organized within 3 domains (pain, disability, and activity restriction). The Index has two versions, the original one (FFI) with a scale from 0 to 9 for each question, and the Spanish version (FFIsp) from 0 to 10. Both make use of a formula, resulting in a final score between 0 to 100%. The aim of this study was to evaluate the performance of both versions of the FFI questionnaire in a cohort of RA patients residing in Argentina.

Methods: Analytical, observational, cross-sectional study. Patients ≥ 18 years with a diagnosis of RA (2010 ACR/EULAR criteria) were included. Sociodemographic and disease characteristics, clinimetric measures and current treatment were recorded. Foot anatomical alterations, and use of devices and adaptations were registered. All patients completed FFI, FFIsp and the Health Assessment Questionnaire Argentine version (HAQ-A), Quality of Life-Rheumatoid Arthritis II (QOL- RA II) and the 5 subscales of the Foot and Ankle Survey (FAOS). Statistical analysis: Descriptive statistics. Internal consistency was evaluated with Cronbach’s α. Association between FFI score, and sociodemographic and disease characteristics was analyzed. Multidimensional FAOS questionnaire, clinimetric measures and composite indices were used to determine criterion validity. The Spearman’s rank correlation coefficient was applied on each functional capacity scale. All p values were corrected using the Bonferroni method.

Results: Sixty-six patients were included: 91% were women, mean age 54 years (SD 12) and median disease duration 90 months (IQR 48-156). Ninety-seven percent were positive for RF and 81% for ACPA, 63.6% had erosive disease and 51.5% extra-articular manifestations. Approximately 42% had foot deformities and altered plantar support, only 6.1% required assistance to walk and 4.6% used assistive devices. Results of clinical measurements can be observed in Table 1. Internal consistency was good for both versions (α-Cronbach= 0.72 & 0.75). Intra-item correlation did not evidence redundant questions. Correlation between domain scores (α-Cronbach=0.97 to 0.99) and the final score (α-Cronbach=0.98) of both versions was excellent. Correlation of both Index with FAOS subscales is shown in Table 2. Disability and activity limitation subscales of FFI and FFIsp showed a high correlation with functionality subscale of FAOS. The correlation of Pain subscales and FAOS pain subscale was also high. Correlation between the limitation subscale and FAOS quality of life subscale was moderate. Both versions of FFI showed a moderate correlation with foot visual analog scale (r=0.60 & 0.60) and a little higher correlation with HAQ-A (r=0.66 & 0.68). The correlation with DAS28 was regular (r=0.40 & 0.38). There was no correlation with sociodemographic characteristics or quality of life.

Conclusion: FFI and FFIsp proved to be reliable and valid in patients with RA, providing a useful tool to evaluate the functional capacity of the foot.

Supporting image 1

Results of clinical measurements

Supporting image 2

Correlation of the final score of both questionnaires with the five FAOS subscales


Disclosures: J. Dapeña, None; L. Alascio, None; E. Serrano, None; J. Bande, None; M. Medina, None; D. Klajn, None; J. Caracciolo, None; S. Papasidero, None.

To cite this abstract in AMA style:

Dapeña J, Alascio L, Serrano E, Bande J, Medina M, Klajn D, Caracciolo J, Papasidero S. Performance of the Foot Function Index Questionnaire in Patients with Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/performance-of-the-foot-function-index-questionnaire-in-patients-with-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/performance-of-the-foot-function-index-questionnaire-in-patients-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology